Nutrition

Nemysis Limited Signs With Kolinpharma SpA an IHAT Sales and Marketing Agreement

DUBLIN, IRELAND / ACCESSWIRE / January 10, 2024 / Nemysis Ltd and Kolinpharma® SpA ("Kolinpharma®") are pleased to announce they…

11 months ago

New Technique Uses Microscopic Bubbles to Blast Cancer With Help From GI Research Foundation

With a $500,000 grant from the GI Research Foundation to Dr. Osman Ahmed, UChicago Medicine will be one of only…

11 months ago

Exousia AI Ludwig Enterprises Subsidiary Launches Liposome Research Program

SPARKS, NV / ACCESSWIRE / January 9, 2024 / Ludwig Enterprises, Inc, (OTC:LUDG): A US based biotechnology company with a…

11 months ago

Liviniti Announces Noom GLP-1 Companion and Comprehensive Weight Management Solution

Liviniti adopts Noom to support sustainable weight loss and healthier outcomes.Natchitoches, Louisiana--(Newsfile Corp. - January 9, 2024) - Liviniti, a…

11 months ago

BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President

ANAHEIM, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and…

11 months ago

Theralogix Launches Mannose One for Next-Level Urinary Tract Protection

ROCKVILLE, MD / ACCESSWIRE / January 8, 2024 / Theralogix, a national leader in the nutritional supplement industry, proudly announces…

11 months ago

BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2024) - BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE:…

11 months ago

Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil

Advanced technology enables the land-based production of omega-3 (EPA+DHA) in Camelina potentially representing a novel solution to the market need…

11 months ago

Smart for Life Announces Completion of Audit for Pending Acquisition

Acquisition Expected to Contribute More than $8 Million of Annualized Revenue and Positive Net IncomeMIAMI, Jan. 05, 2024 (GLOBE NEWSWIRE)…

11 months ago

Issuance of New US Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs)

New patent issued for core rare disease target indication for crofelemerJaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the…

11 months ago